Ultrasonic device and system
The ultrasonic device addresses the side effects of conventional adjuvants by using focused ultrasonic waves to enhance vaccine efficacy through increased antibody production, offering a safer and more effective alternative.
WO2026116281A1 Publication Date: 2026-06-04PIXIE DUST TECH INC
3 Cites 0 Cited by
Patent Information
- Application Number
- PCT/JP2025/040893
- Authority / Receiving Office
- WO · WO
- Patent Type
- Applications
- Current Assignee / Owner
- Priority Date
- 2024-11-26
- Filing Date
- 2025-11-25
- Publication Date
- 2026-06-04
AI Technical Summary
Technical Problem
Existing vaccines often require adjuvants to enhance their efficacy, which can cause side effects such as undesirable immune responses and tissue damage.
Method used
An ultrasonic device that generates and directs focused ultrasonic waves to the vaccination site to promote antibody production, potentially reducing the need for conventional adjuvants and enhancing vaccine effectiveness.
Benefits of technology
The ultrasonic device safely increases antibody production without significant side effects, improving vaccine efficacy by applying acoustic radiation pressure to enhance gene expression in targeted skin areas.
✦ Generated by Eureka AI based on patent content.
Abstract
This ultrasonic device comprises: a means for generating a drive signal for driving an ultrasonic transducer that emits ultrasonic waves; and a means for projecting ultrasonic waves based on the drive signal onto the skin of a subject at a vaccine vaccination position, and thereby promoting, in the subject, the production of antibodies by the vaccine.
Need to check novelty before this filing date? Find Prior Art